FDA on PPI in TPLC (overview)
The new article outlines the key points regarding patient preference information and its use in the context of the product lifecycle.
The new article outlines the key points regarding patient preference information and its use in the context of the product lifecycle.
The article outlines the basics of chemical analysis in the context of biocompatibility of medical devices.
The article outlines the approach to be applied with respect to legacy medical devices in the context of transitional provisions.
The new article provides further clarifications related to gathering additional information.
The new article highlights the key aspects related to the way test articles should be extracted in order to ensure the accuracy and reliability of further assessment.
RegDesk is recognized as a Regulatory Intelligence Representative Vendor! Learn more by reading the 2024 Gartner® Market Guide for Regulatory Intelligence Solutions.
Get the report